BIIB logo

Biogen Inc (BIIB)

Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; SKYCLARYS to treat Friedreich's Ataxia; QALSODY for treating amyotrophic lateral scle...

NASDAQHealthcareDrug Manufacturers - GeneralUSA

公司简介

股票代码
BIIB
ISIN代码
US09062X1037
货币
US Dollar (USD)
IPO日期
1991-09-16

联系信息

公司地址
225 Binney Street, Cambridge, MA, United States, 02142
联系电话
617 679 2000
公司网站
https://www.biogen.com
财年结束
December

财务亮点

市值
$999,999.99
毛利润(TTM)
$999,999.99
资产回报率(TTM)
5.21%
EBITDA
$999,999.99
收入(TTM)
$999,999.99